Skip to main content

Optimization of whole-cell human depletion provides increased sensitivity and microbial genome coverage from respiratory metagenomic assays

Journal
Microbiology spectrum (Q1)
Published
18 November 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Ronan M Doyle, Vishwa Patel, Gul Humayun, Renee Chang, Maria Gumbanmarasigan, Viktorija Vorslava, et al.
PMID
43049149
DOI
10.1128/spectrum.02247-26

Why clinicians should know about it

  • Picked for Microbiology (medical) (top studies of the week, 22 November 2026): Multicentre validation improves respiratory metagenomic diagnostic sensitivity

Abstract

Metagenomics is being adopted worldwide as a laboratory-developed test. We have previously reported a unified metagenomic method for the direct detection of microorganisms from respiratory samples, delivering preliminary results within 6 h with >90% sensitivity for both viral and bacterial pathogens. This has now been deployed across the United Kingdom National Health Service (NHS) through the NHS Respiratory Metagenomics Network. Since this deployment, we have identified a number of improvements to the method to further increase sensitivity. In this manuscript, we report these optimizations, including the addition of a bead-beating cycle, substitution of the endonuclease enzyme, and controlled termination of the endonuclease reaction. This updated protocol (v1.2) resulted in substantially improved assay performance. Validation in 6 NHS hospitals using both protocols in parallel (v1 and v1.2) with 107 clinical respiratory samples demonstrated increased bacterial and viral read recovery in v1.2, translating to higher pathogen genome coverage compared to v1. Overall, bacterial sensitivity for v1.2 was 98% compared to 93% for v1, and viral sensitivity was 90% for v1.2 compared to 80% for v1. This multicenter validation has confirmed reproducibility and scalability of the new protocol, establishing a robust framework for clinical implementation of metagenomics.IMPORTANCEThis work represents the validation of an important major update to the protocol used in the United Kingdom National Health Service (NHS) Respiratory Metagenomics service. The service is now deployed in six major hospitals across the UK, and the results of this multicenter validation, as well as showing improved sensitivity, confirm this is a method that is easy to operate and implement in existing hospital laboratories and still provide a same-day turnaround time. The importance of this work is that it provides another step forward to respiratory metagenomics becoming established as a routine clinical diagnostic method.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.